March 17, 2020 / 12:12 PM / 14 days ago

BRIEF-Surface Oncology Announces First Patient Dosed In Clinical Trial Of Immuno-Oncology Candidate SRF617

March 17 (Reuters) - Surface Oncology Inc:

* SURFACE ONCOLOGY ANNOUNCES FIRST PATIENT DOSED IN CLINICAL TRIAL OF IMMUNO-ONCOLOGY CANDIDATE SRF617

* SURFACE ONCOLOGY INC - EXPECTS TO PROVIDE AN INITIAL CLINICAL UPDATE FROM DOSE ESCALATION PORTION OF SRF617 STUDY BY END OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below